| Serial Number | 98610045 |
| Word Mark | ADIPEARL |
| Filing Date | Thursday, June 20, 2024 |
| Status | 661 - RESPONSE AFTER NON-FINAL ACTION - ENTERED |
| Status Date | Thursday, March 27, 2025 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | NOT AVAILABLE |
| Goods and Services | Pharmaceutical preparations, in particular for tissue enhancement and reconstruction, for treating the loss of soft tissue volume in humans as well as for improving skin quality and volume contours in dermatology for aesthetic medicine, for reconstructive medicine and for reconstructive surgery; medical and veterinary preparations and articles, in particular medical and veterinary preparations for treating the loss of soft tissue volume as well as for improving skin quality and volume contours in dermatology for tissue enhancement and reconstruction; pre-filled syringes filled with pharmaceutical preparations for treating the loss of soft tissue volume in humans as well as for improving skin quality and volume contours in dermatology for medical purposes; Pre-filled vials filled with pharmaceutical preparations for treating the loss of soft tissue volume in humans as well as for improving skin quality and volume contours in dermatology for medical and aesthetic medicine purposes; vials and syringes, pre-filled with a preparation for enabling cellular or tissular assembly for treating the loss of soft tissue volume in humans as well as for improving skin quality and volume contours in dermatology for aesthetic and medical purposes; injectable dermal fillers; biological implants, namely, implants comprising living tissue; implantable medicines for treating the loss of soft tissue volume in humans as well as for improving skin quality and volume contours in dermatology; injectable materials in the nature of injectable gels for treating the loss of soft tissue volume in humans for tissue repair, enhancement, creation or regeneration; implantable materials in the nature of injectable gels for treating the loss of soft tissue volume in humans containing an anaesthetic agent or a pharmaceutical ingredient; injectable materials in the nature of injectable gels for treating the loss of soft tissue volume in humans containing an anaesthetic agent or a pharmaceutical ingredient; none of the aforementioned in relation to medication and drugs for preventing, curing or slowing down the progression of cancer; polysaccharide compositions in the nature of injectable gels for treating the loss of soft tissue volume in humans as well as for improving skin quality and volume contours in dermatology for use in the dermal filler industry; polymeric biomaterials, in particular polymeric biomaterials in the nature of injectable gels for treating the loss of soft tissue volume in humans as well as for improving skin quality and volume contours in dermatology for use in the cell therapy industry; injectable biomaterials in the nature of injectable gels for treating the loss of soft tissue volume in humans as well as for improving skin quality and volume contours in dermatology, in particular for use in aesthetic medicine, aesthetic surgery, reconstructive surgery; injectable biomaterials in the nature of injectable gels for treating the loss of soft tissue volume in humans as well as for improving skin quality and volume contours in dermatology in the form of microgels; injectable biomaterials in the nature of injectable gels for treating the loss of soft tissue volume in humans as well as for improving skin quality and volume contours in dermatology in the form of particles, in the form of paste or putty, in the form of a dry material; implantable biomaterials in the form of three-dimensional volumes; injectable biocompatible material in the nature of injectable gels for treating the loss of soft tissue volume in humans as well as for improving skin quality and volume contours in dermatology used for tissues in particular soft tissues |
| Goods and Services | Chemical polymers for use in the manufacture of pharmaceutical preparations and medical implants; biodegradable polymer compositions for use in the manufacture of pharmaceutical preparations and medical implants; polymeric chemicals for use in the cosmetic industry |
| Goods and Services | Surgical apparatus and instruments; prosthetic and filling materials, namely artificial materials for use in the replacement of soft tissue in humans, and artificial implants; artificial breast implants; medical implants made of artificial materials; biodegradable implants consisting of artificial materials; scaffolding material for the use of three-dimensional shapeable body implants, namely, implantable scaffolds comprising artificial materials for creating new tissue volume or to compensate for tissue volume loss and serving as a scaffold for the regeneration of human tissue; artificial materials for the repair and enhancement of human tissue, namely, implantable scaffolds comprising artificial materials for creating new tissue volume or to compensate for tissue volume loss and serving as a scaffold for the regeneration of human tissue; suture materials; syringes for injections; syringes, vials, containers and sterile bags as part of a kit for preparing a cellular or tissular construct, for preparing a pharmaceutical composition, and for mixing the composition with an anaesthetic agent; medical injection syringes; syringes for medical use; medical syringes for use in aesthetic surgery, in particular, in dermatology and reconstructive surgery; pharmaceutical implants made of artificial materials; implants made of artificial materials for guided tissue regeneration |
| International Class | 001 - Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry; unprocessed artificial resins; unprocessed plastics; manures; fire extinguishing compositions; tempering and soldering preparations; chemical substances for preserving foodstuffs; tanning substances; adhesives used in industry. |
| US Class Codes | 001, 005, 006, 010, 026, 046 |
| Class Status Code | 6 - Active |
| Class Status Date | Thursday, June 20, 2024 |
| Primary Code | 001 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Thursday, June 20, 2024 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 010 - Surgical, medical, dental, and veterinary apparatus and instruments, artificial limbs, eyes, and teeth; orthopedic articles; suture materials. |
| US Class Codes | 026, 039, 044 |
| Class Status Code | 6 - Active |
| Class Status Date | Thursday, June 20, 2024 |
| Primary Code | 010 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| Party Name | Volumina Medical SA |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 99 - Other |
| Address | Epalinges 1066 CH |
| Event Date | Event Description |
| Tuesday, September 24, 2024 | TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS |
| Tuesday, September 24, 2024 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
| Thursday, June 20, 2024 | NEW APPLICATION ENTERED |
| Tuesday, September 24, 2024 | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED |
| Tuesday, September 24, 2024 | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED |
| Monday, January 13, 2025 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Tuesday, January 14, 2025 | ASSIGNED TO EXAMINER |
| Tuesday, January 14, 2025 | NON-FINAL ACTION E-MAILED |
| Tuesday, January 14, 2025 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Tuesday, January 14, 2025 | NON-FINAL ACTION WRITTEN |
| Thursday, March 27, 2025 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Thursday, March 27, 2025 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Thursday, March 27, 2025 | TEAS/EMAIL CORRESPONDENCE ENTERED |